Treatment for Vertigo: From Maneuvers to Medication

Treatment for vertigo depends almost entirely on what is causing it, and the most common cause has one of the most effective treatments in all of medicine: a simple head-repositioning maneuver that can stop the spinning in minutes. Beyond that single scenario, vertigo treatment branches into medication, rehabilitation exercises, dietary changes, injections, psychological therapy, and occasionally surgery. Because “vertigo” is a symptom rather than a diagnosis, getting the right treatment starts with identifying which part of the balance system has gone wrong.

Repositioning Maneuvers for BPPV

Benign paroxysmal positional vertigo, or BPPV, accounts for roughly a quarter to a third of all vertigo cases, making it the most common vestibular disorder. It happens when tiny calcium carbonate crystals drift into one of the semicircular canals of the inner ear, sending false rotation signals to the brain every time you move your head a certain way. The hallmark is brief, intense spinning triggered by rolling over in bed, looking up, or tilting your head.

The Epley maneuver is the first-line treatment for the most typical form, posterior canal BPPV. A clinician guides your head through a specific sequence of positions that coax the loose crystals out of the canal and back into a part of the inner ear where they no longer cause trouble. In a controlled study of 81 patients followed for six months, about nine in ten treated patients reported significant improvement at one month compared with only one in ten who received a sham procedure, and the benefit held at the six-month mark.1Ear, Nose & Throat Journal. Efficacy of the Epley Maneuver for Posterior Canal BPPV: A Long-Term, Controlled Study of 81 Patients Another prospective study found that nearly three-quarters of patients were symptom-free immediately after the maneuver, and over 90% had recovered by one week.2PubMed Central. Efficacy of Epley’s Maneuver in Treating BPPV Patients: A Prospective Observational Study

Not all BPPV involves the posterior canal. When the horizontal (lateral) canal is affected, different maneuvers are needed. The Gufoni maneuver is commonly used for horizontal canal BPPV. In a randomized, double-blind trial, about 76% of patients treated with the Gufoni maneuver had recovered within one hour, compared with roughly 10% in the sham group.3PubMed. Double-blind randomized trial on the efficacy of the Gufoni maneuver for treatment of lateral canal BPPV A systematic review of randomized controlled trials confirmed the Gufoni maneuver works better than sham, though it did not clearly outperform other lateral canal maneuvers like the barbecue roll.4PubMed. Gufoni maneuver for treatment of horizontal canal benign paroxysmal positional vertigo: a systematic review of randomized controlled trials The takeaway is that identifying which canal is involved matters. A skilled clinician can usually figure this out by watching the direction of the eye movements your vertigo produces.

Why Vertigo Medications Should Be Short-Lived

When vertigo hits hard, the instinct is to reach for something that stops the room from spinning. Medications like meclizine, dimenhydrinate, and benzodiazepines can dampen the vestibular signals causing the sensation, and they have a role in acute crises. A single dose of an antihistamine like meclizine may be more effective than a benzodiazepine for quick relief within a couple of hours, and expert guidelines suggest it is reasonable to use vestibular suppressants for a severe episode lasting a few days.5JAMA Otolaryngology–Head & Neck Surgery. Meclizine Use and Subsequent Falls Among Patients With Dizziness

The problem is that these drugs work by sedating the very brain circuits that need to recalibrate after a vestibular injury. If the inner ear on one side has been damaged, the brain must learn to compensate by relying more on the healthy side and on visual and body-position cues. Vestibular suppressants interfere with that relearning process. Longer-term use can delay or even prevent the natural compensation that leads to recovery.6PubMed Central. Vestibular Suppressant Utilization and Subsequent Falls Among Patients 65 Years and Older With Dizziness in the United States A retrospective study of patients with acute one-sided vestibular loss found that those given dimenhydrinate had a larger proportion still experiencing symptoms at three months and showed less recovery of their vestibular reflexes compared with those who were not.7Research in Vestibular Science. Does dimenhydrinate delay recovery of vestibular ocular reflex in acute unilateral vestibulopathy? A retrospective comparative study

Current practice guidelines consistently recommend limiting vestibular suppressants to three to five days at most during an acute crisis. Older adults face additional risk because these sedating medications increase fall hazard on top of the dizziness itself.8PubMed Central. Current Insights into Treating Vertigo in Older Adults

Vestibular Neuritis and the Steroid Debate

Vestibular neuritis is an inflammation of the vestibular nerve, usually from a viral cause, that produces days of severe, constant vertigo. It is distinct from BPPV because the spinning does not come and go with head position; it persists. Most people recover over weeks as the brain compensates, but there has been long-standing interest in whether corticosteroids can speed things along.

One small study found dramatic results when steroids were given very early: all nine patients treated within 24 hours of symptom onset had normal vestibular function tests at three months, compared with just over half of those treated between 25 and 72 hours.9PubMed Central. Steroids for Acute Vestibular Neuronitis—the Earlier the Treatment, the Better the Outcome? A more recent retrospective study similarly supported the idea that early, high-dose steroid treatment helps with symptom relief and recovery of vestibular reflex function.10Research in Vestibular Science. Effect of early high-dose steroid treatment in patients with acute vestibular neuritis: a retrospective case-control study

The catch is that the broader evidence is less convincing. A Cochrane systematic review pooling data from four small trials found that steroids improved inner-ear function tests at one month but had no clear benefit at twelve months and did not reduce patients’ subjective dizziness at any time point.11Cochrane Database of Systematic Reviews. Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis) The trials were small and methodologically weak. In practice, many neurologists and ENT specialists still prescribe a short course of steroids for severe vestibular neuritis, especially if the patient presents quickly, but the evidence base does not firmly settle the question.

Managing Ménière’s Disease

Ménière’s disease involves episodes of vertigo, fluctuating hearing loss, ear fullness, and tinnitus, likely driven by excess fluid pressure in the inner ear. Treatment here is more about managing a chronic condition than delivering a one-time cure.

Dietary salt restriction is a longstanding first-line recommendation. A study of patients who adhered to a low-salt diet found that those who kept sodium below about 3 grams per day achieved complete control of their vertigo episodes, while those who did not restrict as aggressively had more mixed results.12PubMed. Hormonal changes following a low-salt diet in patients with Ménière’s disease A larger retrospective evaluation of patients treated with both diuretics and a low-salt diet found vertigo control was complete or substantial in about four out of five patients after two years.13PubMed. Diuretic and diet effect on Menière’s disease evaluated by the 1985 Committee on Hearing and Equilibrium guidelines

When dietary and medical measures fail, injections through the eardrum become an option. Gentamicin, an antibiotic that is selectively toxic to vestibular hair cells, can chemically ablate the overactive inner ear and dramatically reduce attacks. Intratympanic steroid injections offer an alternative that poses less risk to hearing. In a large randomized double-blind trial, both gentamicin and methylprednisolone injections through the eardrum reduced vertigo attacks by roughly 87% to 90% compared with the six months before treatment, with no significant difference between the two.14The Lancet. Intratympanic gentamicin versus methylprednisolone in unilateral Meniere’s disease: a randomised, double-blind, comparative effectiveness trial A meta-analysis comparing the two found a trend toward better vertigo control with gentamicin, but it was not statistically significant, and steroid injections tended to produce better hearing outcomes.15PubMed. Intratympanic steroid versus gentamicin for treatment of refractory Meniere’s disease: A meta-analysis This means clinicians can often try the hearing-safe steroid option first and reserve gentamicin for truly refractory cases.

Vestibular Migraine

Vestibular migraine is increasingly recognized as one of the most common causes of episodic vertigo, and it is frequently missed because many patients do not have a headache with every attack. The vertigo can last minutes to days and may be accompanied by sensitivity to light, sound, or motion.

Because vestibular migraine shares mechanisms with standard migraine, preventive medications used for migraine headaches are the starting point. A recent network meta-analysis comparing multiple preventive treatments found that all of the studied drugs reduced monthly vertigo attacks compared with placebo. Propranolol ranked highest, followed by valproic acid and venlafaxine. The newer anti-CGRP medication galcanezumab also showed moderate effectiveness and had zero treatment discontinuations in the included trials.16PubMed Central. Comparative effectiveness and safety of preventive treatments for vestibular migraine: a systematic review and network meta-analysis A separate case series specifically examining anti-CGRP drugs found that roughly four out of five vestibular migraine patients experienced at least some improvement, with most describing a global reduction in both dizziness and headache symptoms together.17PubMed Central. New Anti-CGRP Medications in the Treatment of Vestibular Migraine

Vestibular migraine often goes undiagnosed for years because it sits at the intersection of neurology and ENT, and neither specialty always looks for it. If you have recurring vertigo episodes and a personal or family history of migraine, it is worth raising the possibility with your doctor even if headache is not your main symptom.

Vestibular Rehabilitation Therapy

Vestibular rehabilitation therapy, or VRT, is essentially physical therapy for the balance system. It uses graded exercises that challenge your gaze stability, head movement tolerance, and balance to help the brain recalibrate after vestibular damage. It is a core treatment for chronic dizziness from virtually any cause, including after vestibular neuritis, uncompensated BPPV, and persistent postural-perceptual dizziness.

Studies consistently show that patients who complete structured VRT programs improve on both objective balance tests and self-reported dizziness measures.18Otology & Neurotology. Vestibular Rehabilitation Outcomes in Chronic Vertiginous Patients Through Computerized Dynamic Visual Acuity and Gaze Stabilization Test For older adults, the benefits extend beyond symptom relief. In a randomized trial of elderly patients with postural instability, the group receiving vestibular rehabilitation saw their average number of falls drop from about 11 per year to about 3 over the follow-up period, while the control group showed no significant change.19PubMed. Vestibular rehabilitation in elderly patients with postural instability: reducing the number of falls-a randomized clinical trial A separate study of elderly individuals at fall risk found statistically significant improvements across dizziness, gait stability, and posturography measures after rehabilitation, with all participants moving out of the “faller” category.20The Egyptian Journal of Otolaryngology. Fall risk assessment and effect of vestibular rehabilitation in the elderly population

Virtual reality is beginning to supplement traditional VRT. A meta-analysis found that VR-based vestibular rehabilitation significantly reduced dizziness handicap compared with conventional exercises in patients with peripheral vestibular disorders.21Scientific Reports. Virtual and augmented reality in the vestibular rehabilitation of peripheral vestibular disorders: systematic review and meta-analysis Individual studies have reported that patients in VR rehabilitation groups had fewer symptoms during treatment visits and reported higher satisfaction than those doing conventional therapy.22PubMed Central. Virtual Reality Vestibular Rehabilitation in 20 Patients with Vertigo Due to Peripheral Vestibular Dysfunction The VR approach is still evolving, but the underlying principle is the same as traditional VRT: deliberately exposing the balance system to challenging sensory environments so the brain learns to process signals more accurately.

Preventing BPPV From Coming Back

BPPV has a frustrating tendency to recur. Known risk factors for recurrence include older age, being female, and having conditions like osteoporosis, hypertension, or vitamin D deficiency.23PubMed Central. Vitamin D Supplementation and Recurrence of Benign Paroxysmal Positional Vertigo The vitamin D connection makes physiological sense: vitamin D affects calcium metabolism, and the crystals that cause BPPV are calcium carbonate.

Two recent randomized controlled trials have tested whether supplementing vitamin D in deficient patients reduces recurrence. One found a significant reduction in recurrence at both six and twelve months in the vitamin D group compared with placebo, with recurrences also being less frequent per person.24PubMed Central. Vitamin D supplementation in preventing the recurrence of benign paroxysmal positional vertigo Another trial in older adults reported an 87% reduction in BPPV recurrence rates in the treatment group, along with a significantly longer time before any recurrence happened.25PubMed Central. Randomized Controlled Trial Assessing Vitamin D’s Role in Reducing BPPV Recurrence in Older Adults These are still relatively small studies, and supplementation appears to help specifically in people who are actually deficient. If you have had BPPV more than once, checking your vitamin D level is a low-risk, potentially high-reward step.

Persistent Postural-Perceptual Dizziness and the Role of CBT

Persistent postural-perceptual dizziness, or PPPD, is a chronic functional dizziness disorder that often develops after a vestibular event like BPPV or vestibular neuritis has resolved. The original trigger is gone, but the brain remains stuck in a high-alert mode, generating persistent rocking, swaying, or unsteady sensations. Anxiety and avoidance behavior feed back into the symptoms, creating a loop that purely physical treatments do not break.

Standard treatment usually involves SSRIs and vestibular rehabilitation, but adding cognitive behavioral therapy makes a meaningful difference. A meta-analysis of six randomized controlled trials found that patients receiving CBT on top of conventional treatment had significantly greater improvement in dizziness handicap scores, anxiety, and depression compared with those on conventional treatment alone.26PubMed Central. Additional cognitive behavior therapy for persistent postural-perceptual dizziness: a meta-analysis A trial comparing sertraline alone to sertraline plus CBT found that the combination group achieved better dizziness and mood scores and actually needed a lower dose of the medication, with fewer side effects.27PubMed Central. Cognitive Behavior Therapy as Augmentation for Sertraline in Treating Patients with Persistent Postural-Perceptual Dizziness PPPD is worth knowing about because many people with chronic dizziness go through rounds of unhelpful testing and medication without anyone identifying the psychological maintenance cycle that CBT directly targets.

Ginkgo Biloba and Betahistine

Betahistine is the most widely prescribed drug specifically for vertigo in much of the world (though not approved in the United States). It is thought to improve inner-ear blood flow and modulate histamine receptors in the vestibular system. Ginkgo biloba extract EGb 761 has been studied as a comparator, and the results have been unexpectedly close.

A randomized double-blind trial found that Ginkgo biloba extract EGb 761 was at least as effective as betahistine for unspecified vertigo syndromes.28PubMed Central. Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine A more recent randomized controlled trial confirmed these findings, showing similar improvements in dizziness scores for both groups over twelve weeks, with no significant difference in outcomes between the two treatments.29PubMed Central. Efficacy of EGb 761 ® and Betahistine in Treatment of Dizziness/Vertigo: A Randomized Double-Blind Controlled Trial A third comparative study reported that adverse effects were significantly lower with ginkgo (12%) than with betahistine (40%), and patients reported higher satisfaction with the ginkgo group.30Journal of Rawalpindi Medical College. Comparison Between Ginkgo biloba and Betahistine in Treatment of Vertigo: A Prospective Comparative Study

These results are intriguing, but important caveats apply. The trials studied “unspecified” or “chronic” vertigo rather than specific diagnoses like BPPV or Ménière’s disease. Ginkgo biloba products vary enormously in composition; the studied extract (EGb 761) is a standardized pharmaceutical-grade product, not the same as a random supplement from a health-food store shelf. And “as effective as betahistine” is only a strong selling point if betahistine itself is highly effective, which remains debated for many vertigo causes.

When Surgery Becomes an Option

Surgical treatment for vertigo is reserved for patients who have failed conservative approaches and remain severely affected. The procedures range from moderately invasive to dramatic. Endolymphatic sac surgery aims to reduce fluid pressure in Ménière’s disease. Semicircular canal plugging can stop BPPV in the rare cases that do not respond to repositioning maneuvers. At the far end of the spectrum, vestibular nerve section or labyrinthectomy permanently destroys the vestibular input from one ear.

Ablative and destructive procedures generally achieve good vertigo control, but they come with a high risk of hearing loss on the treated side.31PubMed Central. Recent surgical options for vestibular vertigo The decision is highly individual and hinges on whether the patient still has usable hearing in the affected ear, whether the condition is unilateral, and how much their quality of life is already compromised. Surgery is rare as a proportion of all vertigo treatment, but for the right patient, it can be transformative.

Vagus Nerve Stimulation and Vestibular Prostheses

Several newer approaches are still in earlier stages of research but show real promise. Non-invasive vagus nerve stimulation, delivered through a handheld device pressed against the neck, has been tested in both vestibular migraine and PPPD. In a small study of acute vestibular migraine attacks, stimulation reduced vertigo intensity by roughly 47% on average and improved headache even more, with 13 of 14 patients experiencing at least some benefit.32PubMed. Acute vestibular migraine treatment with noninvasive vagus nerve stimulation In patients with otherwise refractory PPPD, vagus nerve stimulation significantly improved quality of life and depression scores compared with standard care alone.33PubMed. Non-invasive vagus nerve stimulation significantly improves quality of life in patients with persistent postural-perceptual dizziness These are preliminary findings and the studies are small, but the approach is attractive because it is non-invasive and has minimal side effects.

For the most severe condition, bilateral vestibular loss, where both inner ears have lost function and no amount of rehabilitation can fully compensate, researchers at Johns Hopkins have been developing a multichannel vestibular prosthesis. The device works on a principle similar to a cochlear implant, but for balance: motion sensors detect head rotation, and electrodes deliver corresponding electrical stimulation to the vestibular nerve. In animal models rendered bilaterally vestibular-deficient, the prosthesis partially restored the vestibulo-ocular reflex for head rotations in all three dimensions.34PubMed Central. Progress toward development of a multichannel vestibular prosthesis for treatment of bilateral vestibular deficiency Human trials are ongoing, and while a commercial device remains years away, it represents a fundamentally new approach for patients who currently have no good options.

Getting the Diagnosis Right

The single biggest barrier to effective vertigo treatment is misdiagnosis or, more often, no specific diagnosis at all. Many patients are told they have “an inner ear problem” and sent home with meclizine, when they could have been cured in five minutes with an Epley maneuver or started on the right preventive medication for vestibular migraine.

One important diagnostic advance is the HINTS exam, a three-step bedside eye-movement test used to distinguish between harmless peripheral vertigo and potentially dangerous posterior circulation stroke in patients with sudden, persistent vertigo. When performed by trained neurologists, HINTS has a sensitivity above 96% and specificity around 95% for detecting stroke, actually outperforming early MRI in some studies.35PubMed Central. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging However, when emergency physicians without specialized training perform the same exam, both sensitivity and specificity drop substantially.36PubMed. Can Emergency Physicians Accurately Rule Out a Central Cause of Vertigo Using the HINTS Examination? A Systematic Review and Meta-analysis The skill of the examiner matters enormously, which means that in many emergency departments, the test is not used at all or is used unreliably.

For children, vertigo diagnosis follows a similar logic but with a different list of likely causes. Vestibular migraine is a leading culprit in pediatric dizziness, and benign paroxysmal vertigo of childhood, which is considered a migraine precursor, tends to resolve on its own. Standard bedside tests can be adapted for kids, and brain imaging is mainly reserved for cases where central neurological signs are present.37PubMed. Vertigo and dizziness in childhood – update on diagnosis and treatment The prognosis for most childhood vertigo syndromes is favorable, which is reassuring for parents who understandably panic when their child reports the room spinning.